Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 982 participants.
Also called NCT03783429
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 982 participants
- Registry
-
NCT03783429
-
- Other papers using this trial's data
- Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03783429. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-01 (actual); primary completion 2025-11-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
- Acronym
- DECISION
- Condition
- Heart Failure
- Intervention (Drug)
- Digoxin
- Intervention (Drug)
- Placebos
- Lead sponsor
- University Medical Center Groningen
- Collaborator
- Disphar International B.V.
- Collaborator
- Teva Nederland BV
- Collaborator
- Tiofarma BV
- Collaborator
- Netherlands Heart Foundation
- Collaborator
- Werkgroep Cardiologische centra Nederland
Record details
- Record id
cardio:ct-nct03783429- Content hash
41a779d9bef0890ddac134e593019e5447e0edc9b1338d24b88551fa62a6aec5